We are live on ! Find out more

454 hedge funds and large institutions have $11.4B invested in Sanofi in 2017 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 154 increasing their positions, 152 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more funds holding in top 10

Funds holding in top 10: 710 (+3)

12% more capital invested

Capital invested by funds: $10.2B → $11.4B (+$1.19B)

1% more repeat investments, than reductions

Existing positions increased: 154 | Existing positions reduced: 152

0.1% less ownership

Funds ownership: 19.43%19.33% (-0.1%)

9% less call options, than puts

Call options by funds: $47.7M | Put options by funds: $52.3M

4% less funds holding

Funds holding: 475454 (-21)

23% less first-time investments, than exits

New positions opened: 47 | Existing positions closed: 61

Holders
454
Holders Change
-21
Holders Change %
-4.42%
% of All Funds
11.3%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.25%
New
47
Increased
154
Reduced
152
Closed
61
Calls
$47.7M
Puts
$52.3M
Net Calls
-$4.61M
Net Calls Change
+$3.7M

SNY Hedge Fund Activity: Q1 2017 in Review

454 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2017, worth a combined $11.4B — up 12% from $10.2B a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of SNY and 47 opened new positions — a net loss of 14 holders — while 152 trimmed existing stakes and 154 added.

The largest buyer was BlackRock, adding an estimated $64.3M. The largest seller was Harris Associates, exiting entirely with an estimated $131M sold.

  • 454 institutional investors held Sanofi (SNY) as of Q1 2017, down from 475 in Q4 2016.
  • Funds reported $11.4B of Sanofi stock for Q1 2017, up 12% quarter-over-quarter.
  • 47 funds opened new Sanofi positions in Q1 2017 and 61 closed out, a net change of -14 holders.
  • The largest Sanofi buyer in Q1 2017 was BlackRock, an estimated $64.3M added.
  • The largest Sanofi seller in Q1 2017 was Harris Associates, an estimated $131M sold.

Based on aggregated 13F filings for Q1 2017.